Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|August 8, 2025
Inferring Phenotypes of Copy Number Clones in Cancer Populations Using TreeAlignHongyu Shi, Matthew Zatzman, Sohrab Shah, et al.Science Advances|November 23, 2022
Widespread hypertranscription in aggressive human cancersMatthew Zatzman, Fabio Fuligni, Ryan Ripsman, et al.Biorxiv : the Preprint Server for Biology|July 14, 2025
Complementary modes of resistance to EGFR TKI in lung adenocarcinoma through MAPK activation and cellular plasticityMatthew Zatzman, Alvaro Quintanal-Villalonga, Sohrab Salehi, et al.Nature Communications|January 5, 2023
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosisNicholas Light, Mehdi Layeghifard, Ayush Attery, et al.Biorxiv : the Preprint Server for Biology|September 4, 2024
Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNAMarc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.Cancer Discovery|February 10, 2021
Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK InhibitionBrittany B Campbell, Melissa A Galati, Simone C Stone, et al.Nature|October 1, 2025
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNAMarc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.Nature Communications|July 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survivalNathaniel D Anderson, Yael Babichev, Fabio Fuligni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric CancerSteven B Maron, Walid Chatila, Henry Walch, et al.Science (New York, N.Y.)|September 5, 2024
Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancersLaksshman Sundaram, Arvind Kumar, Matthew Zatzman, et al.Pageof 2